Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice

Cancer Research

Volumn 60, Issue 18, 2000, Pages 5158-5164

  Forrest, G L ^a   Gonzalez, B ^a   Tseng, W ^a   Li, X ^a   Mann, J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL REDUCTASE; CREATINE KINASE; DOXORUBICIN; DOXORUBICINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; DRUG METABOLISM; ELECTRON MICROSCOPY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TRANSGENIC MOUSE;

ALCOHOL OXIDOREDUCTASES; ANIMAL; ANTIBIOTICS, ANTHRACYCLINE; CREATINE KINASE; DISEASE MODELS, ANIMAL; DOXORUBICIN; ELECTROCARDIOGRAPHY, AMBULATORY; HEART DISEASES; HUMAN; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MITOCHONDRIA, HEART; MYOCARDIUM; ORGAN SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0034665414     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Cytoprotective agents for anthracyclines
2. Anthracycline-induced cardiotoxicity
3. A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia
4. Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses
5. The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps
6. Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells
7. Anthracyclines and their C-13 alcohol metabolites: Growth inhibition and DNA damage following incubation with human tumor cells in culture
8. Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cells
9. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol
10. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers
11. Mammalian carbonyl reductases
12. Cellular pharmacodynamics of several anthracycline antibiotics
13. Isolation and characterization of the mouse cardiac myosin heavy chain genes
14. Induction of a human carbonyl reductase gene located on chromosome 21
15. Isolation of high molecular weight DNA for reliable genotyping of transgenic mice
16. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity
17. Daunorubicin reductase activity in human normal lymphocytes, myeloblasts and leukemic cell lines
18. Loop-column extraction and liquid chromatographic analysis of doxorubicin and three metabolites in plasma
19. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods
20. Cytoplasmic aldo-keto reductases. A class of drug metabolizing enzymes
21. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase
22. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man
23. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors
24. Measurement of the S α T segment as the most reliable electrocardiogram parameter for the assessment of Adriamycin-induced cardiotoxicity in the rat
25. Redox regulation of signal transduction in cardiac and smooth muscle
26. Daunorubicinol, a major metabolite of daunorubicin: Isolation from human urine and enzymatic reactions
27. Daunorubicin reduction mediated by aldehyde and ketone reductases
28. Isolation and characterization of rabbit liver xenobiotic carbonyl reductases
29. Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function
30. Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats
31. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium
32. Might adriamycinol contribute to Adriamycin-induced cardiotoxicity?
33. General and cardiac toxicity of adriamycinol in rats
34. Actin isoform mRNA alterations induced by doxorubicin in cultured heart cells
35. Anthracycline effects on actin and actin-containing thin filaments in cultured neonatal rat myocardial cells
36. Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes
37. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro
38. Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sarcoplasmic reticulum
39. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin
40. Effect of anthracycline antibiotics on oxygen radical formation in rat heart
41. Adriamycin-induced free radical formation in the perfused rat heart: Implications for cardiotoxicity
42. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase
43. Analyses of the molecular mechanism of Adriamycin-induced cardiotoxicity
44. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
45. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation
46. Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenase
47. Doxorubicin, daunorabicin, and mitoxantrone cytotoxicity in yeast
48. The protective role of manganese superoxide dismutase against Adriamycin-induced acute cardiac toxicity in transgenic mice
49. Manganese superoxide dismutase protects mitochondrial complex I against Adriamycin-induced cardiomyopathy in transgenic mice